
Illinois Appeals Court Affirms $45 Million J&J Talc Verdict, Upholds Survival Act Damages
On July 10, 2026, an Illinois appellate panel affirmed a $45 million talc mesothelioma verdict against Johnson & Johnson, upholding a $30 million Survival Act shortened-life-expectancy award.









